SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
Authors: Shields AM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Venkatachalam S; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Shafeek S; Department of Haematology, Worcestershire Acute NHS Trust, Worcester, UK., Paneesha S; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Ford M; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Sheeran T; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kelly M; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Qureshi I; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Salhan B; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Karim F; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., De Silva N; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Stones J; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Lee S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Khawaja J; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kaudlay PK; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Whitmill R; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kakepoto GN; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Parry HM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Faustini SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Richter AG; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Basu S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK.
Source: Clinical and experimental immunology [Clin Exp Immunol] 2022 Jan 28; Vol. 207 (1), pp. 3-10.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2249
DOI:10.1093/cei/uxab018